Research And Development Tenders

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Ranibizumab, as a Vial (S01la04) as Part of an Open House Model.

Dynamic Purchasing System (Das) Hire Third Parties

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Para. 8/130C Para. 1 Sgb V for Drugs with the Active Ingredient Interferon Beta-1B (L03ab08) as Part of a So-Called Open House Model.

23/024 - Procurement Advisory Services

Hearing Officers - 24

Innovation for Hiv Vaccine Discovery (R01 Clinical Trial not Allowed)

Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)

Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials not Allowed)

Deployment of Shared Virtual Server Infrastructure 1 Set

System Integration of Endopoint Security Software 1 Set